Tariffs Will Hurt Americans, Won’t Solve Fentanyl Crisis
President-elect Trump’s proposed tariffs on goods from Canada, China, and Mexico to combat drug trafficking would impose a significant tax burden on American consumers and businesses, potentially costing the average family nearly $1200 annually. These tariffs, unlikely to effectively curb the drug trade, could disrupt vital supply chains and invite retaliatory measures from affected countries, jeopardizing American exports and jobs. Furthermore, such actions might simply shift the drug trade to more dangerous substances, exacerbating the crisis. Ultimately, this approach risks harming the U.S. economy while failing to address the core issue of drug addiction.